[The EARLY ACS study].
Galli
Michele
M
U.O. di Cardiologia, Spedali Riuniti ASL6, Livorno. m.galli@nord.usl6.toscana.it
Carluccio
Marisa
M
Campo
Gianluca
G
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D016001:Confidence Intervals; D004311:Double-Blind Method; D004562:Electrocardiography; D000077542:Eptifibatide; D006801:Humans; D007558:Italy; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology / Q000628:therapy; D016017:Odds Ratio; D010455:Peptides / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D016019:Survival Analysis; D013997:Time Factors
D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide